ID: ALA2336374

Max Phase: Preclinical

Molecular Formula: C12H20N8O

Molecular Weight: 292.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)n1cnc2c(NC(=N)N)nc(NCCCO)nc21

Standard InChI:  InChI=1S/C12H20N8O/c1-7(2)20-6-16-8-9(17-11(13)14)18-12(19-10(8)20)15-4-3-5-21/h6-7,21H,3-5H2,1-2H3,(H5,13,14,15,17,18,19)

Standard InChI Key:  UCVJJUUVYWUKLA-UHFFFAOYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.35Molecular Weight (Monoisotopic): 292.1760AlogP: 0.51#Rotatable Bonds: 6
Polar Surface Area: 137.76Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.94CX LogP: -0.21CX LogD: -0.85
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.30Np Likeness Score: -0.62

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source